RU 486 research forges on, despite political hurdles.
Watanabe
M E
ME
D000302:Adrenal Cortex; D000569:Americas; D001695:Biology; D001943:Breast Neoplasms; D002490:Central Nervous System; D002986:Clinical Trials as Topic; D019049:Developed Countries; D004194:Disease; D004467:Economics; D004702:Endocrine Glands; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005376:Financial Management; D005380:Financing, Government; D005835:Genitalia; D005836:Genitalia, Female; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D009369:Neoplasms; D009656:North America; D010827:Physiology; D011057:Politics; D011287:Prejudice; D012106:Research; D012940:Social Problems; D014481:United States; D014566:Urogenital System; D014599:Uterus
D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Adrenal Cortex Effects--prevention and control; Americas; Biology; Breast Cancer--prevention and control; Cancer; Central Nervous System; Central Nervous System Effects--prevention and control; Clinical Research; Clinical Trials; Critique; Developed Countries; Diseases; Economic Factors; Endocrine Effects; Endocrine System; Financial Activities; Financing, Government; Genitalia; Genitalia, Female; Hormone Antagonists; Hormones; Neoplasms; North America; Northern America; Physiology; Political Factors; Ru-486; Sex Discrimination; Social Discrimination; Social Problems; United States; Urogenital System; Uterine Effects--prevention and control; Uterus